Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial
JAMA 2024 Feb 07;[EPub Ahead of Print], H Kamel, WT Longstreth, DL Tirschwell, RA Kronmal, RS Marshall, JP Broderick, R Aragón García, P Plummer, N Sabagha, Q Pauls, C Cassarly, CR Dillon, MR Di Tullio, EA Hod, EZ Soliman, DJ Gladstone, JS Healey, M Sharma, S Chaturvedi, LS Janis, B Krishnaiah, F Nahab, SE Kasner, RJ Stanton, DO Kleindorfer, M Starr, TR Winder, WM Clark, BR Miller, MSV ElkindFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.